Ex vivo use of leukemia-derived modified cells for enhancing efficacy of adoptive cell therapy

The present disclosure provides ex vivo methods of utilizing modified cells of leukemia origin to enhance the efficacy of adoptive cellular therapy. 本公开内容提供了利用白血病来源的经修饰细胞以增强过继性细胞治疗效力的离体方法。

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MANTING ERIC HANS, ROOVERS JEROEN, SINGH SAVINDER KAUR
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides ex vivo methods of utilizing modified cells of leukemia origin to enhance the efficacy of adoptive cellular therapy. 本公开内容提供了利用白血病来源的经修饰细胞以增强过继性细胞治疗效力的离体方法。